Literature DB >> 6788880

P-24: a human leukemia-associated and lymphohemopoietic progenitor cell surface structure identified with monoclonal antibody.

J H Kersey, T W LeBien, C S Abramson, R Newman, R Sutherland, M Greaves.   

Abstract

This study was directed at surface structures that are found on human lymphohemopoietic progenitor cells in normal and leukemic bone marrow. A monoclonal antibody was produced against an acute lymphoblastic leukemia (ALL) cell line of the pre-B phenotype; this antibody (BA-2) was used to demonstrate a cell surface polypeptide of approximately 24,000 mol wt that migrates similarly in both reduced and nonreduced form. This polypeptide, p24/BA-2, was shown by immune precipitation and gel electrophoresis and cell distribution studies to be different from HLA-DR and gp 100/cALLa. p24/BA-2 was present on the surface of 77% (54/70) of cases of non-T, non-B ALL; BA-2 staining was less bright or nondetectable in surface Ig+ (SIg+) chronic lymphocytic leukemia (CLL) and T ALL and nondetectable on peripheral T and B lymphocytes. Approximately 3% of bone marrow mononuclear cells were p24/BA-2+, and these cells were E rosette-, surface (SIg-), and nonphagocytic. Marrow TdT+ progenitor cells were frequently p 24/BA-2+. Results suggest that p24/BA-2 represents a surface structure present on lymphohemopoietic bone marrow progenitor cells and that most common types of ALL bear the p25/BA-2 structure.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6788880      PMCID: PMC2186112          DOI: 10.1084/jem.153.3.726

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Expression of an antigen associated with acute lymphoblastic leukemia in human leukemia-lymphoma cell lines.

Authors:  J Minowada; G Janossy; M F Greaves; T Tsubota; B I Srivastava; S Morikawa; E Tatsumi
Journal:  J Natl Cancer Inst       Date:  1978-06       Impact factor: 13.506

Review 3.  Patterns of gene expression and the cellular origins of human leukaemias.

Authors:  M Greaves; G Janossy
Journal:  Biochim Biophys Acta       Date:  1978-10-27

4.  Pre-B-cell leukemia. A new phenotype of childhood lymphoblastic leukemia.

Authors:  L B Vogler; W M Crist; D E Bockman; E R Pearl; A R Lawton; M D Cooper
Journal:  N Engl J Med       Date:  1978-04-20       Impact factor: 91.245

5.  Leukemia-associated antigens in man.

Authors:  G Brown; D Capellaro; M Greaves
Journal:  J Natl Cancer Inst       Date:  1975-12       Impact factor: 13.506

6.  Characterization of a leukemic cell line of the pre-B phenotype.

Authors:  R Hurwitz; J Hozier; T LeBien; J Minowada; K Gajl-Peczalska; I Kubonishi; J Kersey
Journal:  Int J Cancer       Date:  1979-02       Impact factor: 7.396

7.  Distribution of Ia-like molecules on the surface of normal and leukemic human cells.

Authors:  S F Schlossman; L Chess; R E Humphreys; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

8.  Acute lymphoblastic leukemia with pre-B-cell characteristics.

Authors:  J C Brouet; J L Preud'homme; C Penit; F Valensi; P Rouget; M Seligmann
Journal:  Blood       Date:  1979-07       Impact factor: 22.113

9.  The occurrence of the HL-B alloantigens on the cells of unclassified acute lymphoblastic leukemias.

Authors:  S M Fu; R J Winchester; H G Kunkel
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

10.  Isolation and immunological characterization of a major surface glycoprotein (gp54) preferentially expressed on certain human B cells.

Authors:  C Y Wang; S M Fu; H G Kunkel
Journal:  J Exp Med       Date:  1979-06-01       Impact factor: 14.307

View more
  60 in total

1.  Blocking of feline immunodeficiency virus infection by a monoclonal antibody to CD9 is via inhibition of virus release rather than interference with receptor binding.

Authors:  A de Parseval; D L Lerner; P Borrow; B J Willett; J H Elder
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Anti-CD9 antibodies augment neutrophil adherence to endothelium.

Authors:  K D Forsyth
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

3.  Immunohistochemical distribution of the tetraspanin CD9 in normal porcine tissues.

Authors:  Noemí Yubero; Angeles Jiménez-Marín; Concepción Lucena; Manuel Barbancho; Juan J Garrido
Journal:  Mol Biol Rep       Date:  2010-06-29       Impact factor: 2.316

4.  Immunohistochemical analysis on normal nephrogenesis and Wilms' tumour using monoclonal antibodies reactive with lymphohaemopoietic antigens.

Authors:  E Ishii; J Fujimoto; S Tanaka; J Hata
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

Review 5.  Tetraspanins and vascular functions.

Authors:  Feng Zhang; Jayaprakash Kotha; Lisa K Jennings; Xin A Zhang
Journal:  Cardiovasc Res       Date:  2009-02-27       Impact factor: 10.787

6.  Quantitative analysis of surface plasma membrane proteins of primary and metastatic melanoma cells.

Authors:  Haibo Qiu; Yinsheng Wang
Journal:  J Proteome Res       Date:  2008-04-15       Impact factor: 4.466

7.  Assignment of the human CD9 gene to chromosome 12 (region P13) by use of human specific DNA probes.

Authors:  P Benoit; M S Gross; P Frachet; J Frézal; G Uzan; C Boucheix; V C Nguyen
Journal:  Hum Genet       Date:  1991-01       Impact factor: 4.132

8.  Serological analysis of cell surface antigens of null cell acute lymphocytic leukemia by mouse monoclonal antibodies.

Authors:  R Ueda; M Tanimoto; T Takahashi; S Ogata; K Nishida; R Namikawa; Y Nishizuka; K Ota
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

9.  Langerhans cells in various benign and malignant pigment-cell lesions of the skin.

Authors:  F Facchetti; C de Wolf-Peeters; H de Greef; V J Desmet
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

10.  Characterization of early lymphoid precursor cells in the human fetus using monoclonal antibodies and anti-terminal deoxynucleotidyl transferase.

Authors:  G E Asma; R L van den Bergh; J M Vossen
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.